Lupus Research Alliance News
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA

May 1, 2023 The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio, Inc. that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CABA-201, a CAR T cell investigational therapy in development to treat systemic lupus erythematosus and lupus nephritis – a common […] READ MORE

ManyOne ARE Making the Difference

May 1, 2023 Last year, the Lupus Research Alliance launched our ManyOne Can campaign during Lupus Awareness Month to offer opportunities to get involved in our efforts to transform lives of people with lupus. This Lupus Awareness Month, we celebrate the great successes that are already being achieved and exciting ventures coming up that involve […] READ MORE

Ten Tips During Stress Awareness Month and Beyond

April, 2023 Tips to Lower Stress During Stress Awareness Month and Beyond If you are a person with lupus and often feel stress, you’re not alone! Research has shown stress is common among people dealing with a chronic condition like lupus and can cause symptoms like depression, fatigue, and disease flares. In recognition of Stress […] READ MORE

Lupus Research Alliance Announces Four New Recipients of the Lupus Mechanisms and Targets Award

Winning projects will explore new potential treatment approaches to prevent lupus from developing or prevent or slow disease progression. New York, NY, April 20, 2023. The Lupus Research Alliance (LRA) today announced the newest Lupus Mechanisms and Targets Award grant recipients. The winning four projects collectively test potential treatment approaches to prevent lupus from developing […] READ MORE

Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership

Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs  Washington, DC, March 29, 2023 – The Lupus Research Alliance (LRA) today announced the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership bringing people with lupus together in collaboration with the U.S. Food and Drug Administration (FDA), […] READ MORE

Rinvoq Advances to Phase 3 in Lupus

March 27, 2023 Based on positive results of a Phase 2 clinical trial testing upadacitinib (Rinvoq®) given alone or with elsubrutinib once daily for moderate to severe systemic lupus erythematosus, developer AbbVie is advancing the drug to a Phase 3 trial. The trial also showed that steroid dose either went down or stayed the same […] READ MORE

Consider Donating Your Brain to Lupus Research

During 2023 Brain Awareness Week, it’s important to bring attention to how lupus affects this vital organ.  We know that lupus can cause symptoms that include depression, brain fog, and headaches, as well as cognitive issues with memory and ability to think clearly.  Yet our understanding of how and why lupus impacts the brain is […] READ MORE

3 Questions with Dr. Ashira Blazer

March 8, 2023 As part of our researcher interview series, we are featuring 3 Questions with Ashira Blazer, MD, at Hospital for Special Surgery — one of our Diversity in Lupus Research Award recipients. Below Dr. Blazer explains why she focused her career on lupus, and explains how the project LRA is funding will help […] READ MORE

Run 2024 TCS New York City Marathon For Lupus Research

March 8, 2024 Our Team Life Without Lupus® will once again join the 50,000+ runners in the TCS New York City Marathon Sunday November 3, 2024 running the 26.2 mile course of this iconic international event. Have you or someone you know imagined running a marathon? This year, run for Team Life Without Lupus® to […] READ MORE

DoD’s Lupus Research Program – Created Through LRA Advocacy Leadership – Announces 12 New Grant Recipients

February 28, 2023 The Lupus Research Program (LRP) within the Department of Defense that you, our community, advocated to create, has recommended to fund 12 new applications for promising scientific studies to improve treatment for lupus. The dedicated Lupus Research Program was first established in 2017 under the Congressionally Directed Medical Research Programs operated by […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates